BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was PLN 8.62 million compared to PLN 5.55 million a year ago. Net loss was PLN 0.758 million compared to PLN 1.18 million a year ago.

Basic loss per share from continuing operations was PLN 0.01 compared to PLN 0.02 a year ago. Diluted loss per share from continuing operations was PLN 0.01 compared to PLN 0.02 a year ago.